Epidemiology of invasive Streptococcus pneumoniae infections in adults in Finland

Epidemiology and Infection

Volumn 118, Issue 1, 1997, Pages 7-15

  Sankilampi, U ^a   Herva, E ^a   Haikala, R ^a   Liimatainen, O ^b   Renkonen, O V ^c   Leinonen, M ^a  

^a NATIONAL PUBLIC HEALTH INSTITUTE   (Finland)

^b TAMPERE UNIVERSITY HOSPITAL   (Finland)

^c UNIVERSITY OF HELSINKI   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; PENICILLIN G; PNEUMOCOCCUS POLYSACCHARIDE; PNEUMOCOCCUS VACCINE;

ADOLESCENT; ADULT; AGE; AGED; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTEREMIA; BACTERIAL MENINGITIS; FEMALE; FINLAND; HUMAN; MAJOR CLINICAL STUDY; MALE; STREPTOCOCCUS INFECTION; STREPTOCOCCUS PNEUMONIAE;

ADOLESCENT; ADULT; AGE FACTORS; AGED; BACTEREMIA; FEMALE; FINLAND; HUMANS; INCIDENCE; MALE; MENINGITIS, PNEUMOCOCCAL; MICROBIAL SENSITIVITY TESTS; MIDDLE AGED; PENICILLINS; RECURRENCE; SEROTYPING; STREPTOCOCCAL INFECTIONS; STREPTOCOCCUS PNEUMONIAE; TIME FACTORS;

EID: 0031051248     PISSN: 09502688     EISSN: None     Source Type: Journal    
DOI: 10.1017/S0950268896007169     Document Type: Article

References (38)

1. Burman LÅ, Trollfors B, Andersson B, et al. Diagnosis of pneumonia by cultures, bacterial and viral antigen detection tests, and serology with special reference to antibodies against pneumococcal antigens. J. Infect Dis 1991; 163: 1087-93.
2. Luby JP. Infections of the central nervous system. Am J Med Sci 1992; 304: 379-91.
3. Roberts FJ, Geere IW, Coldman A. A three-year study of positive blood cultures, with emphasis on prognosis. Rev Infect Dis 1991; 13: 34-46.
4. Kragsbjerg P, Källman J, Olcén P. Pneumococcal meningitis in adults. Scand J Infect Dis 1994; 26: 659-66.
5. Kirkpatrick B, Reeves DS, MacGovan AP. A review of the clinical presentation, laboratory features, antimicrobial therapy and outcome of 77 episodes of pneumococcal meningitis occurring in children and adults. J Infect 1994; 29: 171-82.
6. Ruben FL, Norden CW, Korica Y. Pneumococcal bacteremia at a medical/surgical hospital for adults between 1975 and 1980. Am J Med 1984; 77: 1091-4.
7. Kramer MR, Rudensky B, Hadas-Halperin I, Isacsohn M, Melzer E. Pneumococcal bacteremia - no change in mortality in 30 years: analysis of 104 cases and review of the literature. Isr J Med Sci 1987; 23: 174-80.
8. Kuikka A, Syrjänen J, Renkonen OV, Valtonen V. Pneumococcal bacteremia during a recent decade. J Infect 1992; 24: 157-68.
9. Gruer LD, McKendrick MW, Geddes AM. Pneumococcal bacteremia - a continuing challenge. Q J Med 1984; 210: 259-70.
10. Watson DA, Musher DM, Verhoef J. Pneumococcal virulence factors and host immune responses to them. Eur J Clin Microbiol Infect Dis 1995; 14: 479-90.
11. Williams WW, Hickson MA, Kane MA, Kendal AP, Spika JS, Hinman AR. Immunization policies and vaccine coverage among adults: the risk for missed opportunities. Ann Intern Med 1988; 108: 616-25.
12. Nissinen A, Leinonen M, Huovinen P, et al. Antimicrobial resistance of Streptococcus pneumoniae in Finland, 1987-1990. Clin Infect Dis 1995; 20: 1275-80.
13. Tomasz A. The pneumococcus at the gates. N Engl J Med 1995; 333: 514-15.
14. Eskola J, Takala AK, Kela E, Pekkanen E, Kalliokoski R, Leinonen M. Epidemiology of invasive pneumococcal infections in children in Finland. JAMA 1992; 26: 3323-7.
15. Jokinen C, Heiskanen L, Juvonen H, et al. Incidence of community-acquired pneumonia in the population of four municipalities in eastern Finland. Am J Epidemiol 1993; 137: 977-88.
16. Schwartz B, Brieman RF. Pneumococcal immunization: From policy to practice. JAMA 1990; 264: 1154-5.
17. Centers for Disease Control. Influenza and pneumococcal vaccination coverage levels among persons aged ≥ 65 years- United States, 1973-1993. MMWR 1995; 44: 506-15.
18. Burman LÅ, Norrby R, Trollfors B. Invasive pneumococcal infections: incidence, predisposing factors, and prognosis. Rev Infect Dis 1985; 7: 133-42.
19. Örtqvist Å, Kalin M. Bacteremic pneumococcal pneumonia in Stockholm, Sweden, in 1984. Scand J Infect Dis 1988; 20: 451-2.
20. Campbell JF, Donohue MA, Mochizuki RB, NevinWoods CL, Spika JS. Pneumococcal bacteremia in Hawaii: initial findings of a pneumococcal disease prevention project. Hawaii Med J 1989; 48: 517-18.
21. Bennett NM, Buffington J, LaForce FM. Pneumococcal bacteremia in Monroe County, New York. Am J Public Health 1992; 82: 1513-16.
22. Davidson M, Parkinson AJ, Bulkow LR, Fitzgerald MA, Peters HV, Parks DJ. The epidemiology of invasive pneumococcal disease in Alaska, 1986-1990 - ethnic differences and opportunities for prevention. J. Infect Dis 1994; 170: 368-76.
23. Trotman J, Hughes B, Mollison L. Invasive pneumococcal disease in central Australia. Clin Infect Dis 1995; 20: 1553-6.
24. Koivula I, Sten M, Mäkelä PH. Risk factors for pneumonia in the elderly. Am J Med 1994; 93: 313-20.
25. Lipsky BA, Boyko EJ, Inui TS, Koepsell TD. Risk factors for acquiring pneumococcal infections. Arch Intern Med 1986; 146: 2179-85.
26. Örtqvist Å, Grepe A, Julander I, Kalin M. Bacteremic pneumococcal pneumonia in Sweden: clinical course and outcome and comparison with non-bacteremic pneumococcal and mycoplasmal pneumonias. Scand J Infect Dis 1988; 20: 163-71.
27. Isoaho R, Puolijoki H, Huhti E, Kivelä S, Laippala P, Tala E. Prevalence of chronic obstructive pulmonary disease in elderly Finns. Respir Med 1994; 88: 571-80.
28. Korppi M, Heiskanen-Kosma T, Jalonen E, et al. Aetiology of community-acquired pneumonia in children treated in hospital. Eur J Pediatr 1993; 152: 24-30.
29. Hedlund J, Svenson SB, Kalin M, et al. Incidence, capsular types, and antibiotic susceptibility of invasive Streptococcus pneumoniae in Sweden. Clin Infect Dis 1995; 21: 948-53.
30. Ekman MR, Leinonen M, Syrjälä H, Linnanmäki E, Kujala P, Saikku P. Evaluation of serological methods in the etiological diagnosis of Chlamydia pneumoniae pneumonia during an epidemic in Finland. Eur J Clin Microbiol Infect Dis 1993; 12: 756-60.
31. Kauppinen MT, Herva E, Kujala P, Leinonen M, Saikku P, Syrjälä H. The etiology of community-acquired pneumonia among hospitalized patients during a Chlamydia pneumoniae epidemic in Finland. J Infect Dis 1995; 172: 1330-5.
32. Haglund LA, Istre GR, Pickett DA, Welch DF, Fine DP. Pneumococcus study group. Invasive pneumococcal disease in Central Oklaholma: emergence of high-level penicillin resistance and multiple antibiotic resistance. J Infect Dis 1993; 168: 1532-6.
33. Parkinson AJ, Davidson M, Fitzgerald MA, Bulkow LR, Parks DJ. Serotype distribution and antimicrobial resistance patterns of invasive isolates of Streptococcus pneumoniae: Alaska 1986-1990. J Infect Dis 1994; 170: 461-4.
34. Nielsen SV, Henrichsen J. Capsular types and susceptibility to penicillin of pneumococci isolated from cerebrospinal fluid or blood in Denmark, 1983-1988. Scand J Infect Dis 1993; 25: 165-70.
35. Burman LÅ, Trollfors B, Norrby R, Falsen E, Haidl S, Henrichsen J. Serotype distribution of Streptococcus pneumoniae strains isolated from blood and cerebrospinal fluid in Sweden. Scan J Infect Dis 1986; 18: 45-8.
36. Verhaegen J, Glupczynski Y, Verbist L, et al. Capsular types and antibiotic susceptibility of pneumococci isolated from patients in Belgium with serious infections, 1980-1993. Clin Infect Dis 1995; 20: 1339-45.
37. Nielsen SV, Henrichsen J. Capsular types of Streptococcus pneumoniae isolated from blood and CSF during 1982-1987. Clin Infect Dis 1992; 15: 794-8.
38. Sibakov M, Herva E, Mäkelä PH. Penicillin-resistant pneumococcus in Finland. Fin Med J 1979; 34: 2668-70.